148 related articles for article (PubMed ID: 34436020)
21. Unproven stem cell-based interventions & physicians' professional obligations; a qualitative study with medical regulatory authorities in Canada.
Zarzeczny A; Clark M
BMC Med Ethics; 2014 Oct; 15():75. PubMed ID: 25315976
[TBL] [Abstract][Full Text] [Related]
22. Do oncologists believe new cancer drugs offer good value?
Nadler E; Eckert B; Neumann PJ
Oncologist; 2006 Feb; 11(2):90-5. PubMed ID: 16476830
[TBL] [Abstract][Full Text] [Related]
23. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
Santiago-Delefosse M; Cahen F; Coeffin-Driol C
Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
[TBL] [Abstract][Full Text] [Related]
24. Perceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in Oncology.
Sacristán JA; Lizan L; Comellas M; Garrido P; Avendaño C; Cruz-Hernández JJ; Espinosa J; Dilla T
Adv Ther; 2016 Nov; 33(11):2059-2068. PubMed ID: 27718158
[TBL] [Abstract][Full Text] [Related]
25. Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety.
Blum AB; Shea S; Czeisler CA; Landrigan CP; Leape L
Nat Sci Sleep; 2011; 3():47-85. PubMed ID: 23616719
[TBL] [Abstract][Full Text] [Related]
26. Physicians' attitudes toward patients' use of alternative cancer therapies.
Bourgeault IL
CMAJ; 1996 Dec; 155(12):1679-85. PubMed ID: 8976333
[TBL] [Abstract][Full Text] [Related]
27. Oncologists' Views on Using Value to Guide Cancer Treatment Decisions.
Gidwani-Marszowski R; Nevedal AL; Blayney DW; Patel M; Kelly PA; Timko C; Ramchandran K; Murrell SS; Asch SM
Value Health; 2018 Aug; 21(8):931-937. PubMed ID: 30098670
[TBL] [Abstract][Full Text] [Related]
28. Understanding patients' attitudes toward communication about the cost of cancer care.
Bullock AJ; Hofstatter EW; Yushak ML; Buss MK
J Oncol Pract; 2012 Jul; 8(4):e50-8. PubMed ID: 23180999
[TBL] [Abstract][Full Text] [Related]
29. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
30. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
31. The utility of cost discussions between patients with cancer and oncologists.
Zafar SY; Chino F; Ubel PA; Rushing C; Samsa G; Altomare I; Nicolla J; Schrag D; Tulsky JA; Abernethy AP; Peppercorn JM
Am J Manag Care; 2015 Sep; 21(9):607-15. PubMed ID: 26618364
[TBL] [Abstract][Full Text] [Related]
32. Approved but non-funded vaccines: accessing individual protection.
Scheifele DW; Ward BJ; Halperin SA; McNeil SA; Crowcroft NS; Bjornson G
Vaccine; 2014 Feb; 32(7):766-70. PubMed ID: 24374500
[TBL] [Abstract][Full Text] [Related]
33. Views of psycho-oncologists, physicians, and nurses on cancer care-A qualitative study.
Steven B; Lange L; Schulz H; Bleich C
PLoS One; 2019; 14(1):e0210325. PubMed ID: 30650112
[TBL] [Abstract][Full Text] [Related]
34. Attitude of Iranian Medical Oncologists Toward Economic Aspects, and Policy-making in Relation to New Cancer Drugs.
Daroudi R; Mirzania M; Zendehdel K
Int J Health Policy Manag; 2015 Oct; 5(2):99-105. PubMed ID: 26927395
[TBL] [Abstract][Full Text] [Related]
35. Cost health literacy as a physician skill-set: the relationship between oncologist reported knowledge and engagement with patients on financial toxicity.
Fischer KA; Walling A; Wenger N; Glaspy J
Support Care Cancer; 2020 Dec; 28(12):5709-5715. PubMed ID: 32193693
[TBL] [Abstract][Full Text] [Related]
36. An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM).
Lee RT; Hlubocky FJ; Hu JJ; Stafford RS; Daugherty CK
Integr Cancer Ther; 2008 Jun; 7(2):70-5. PubMed ID: 18505899
[TBL] [Abstract][Full Text] [Related]
37. Oncologists' attitudes toward KRAS testing: a multisite study.
Harris JN; Liljestrand P; Alexander GL; Goddard KA; Kauffman T; Kolevska T; McCarty C; O'Neill S; Pawloski P; Rahm A; Williams A; Somkin CP
Cancer Med; 2013 Dec; 2(6):881-8. PubMed ID: 24403261
[TBL] [Abstract][Full Text] [Related]
38. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
39. Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia.
Agarwal A; Karikios DJ; Stockler MR; Morton RL
PLoS One; 2022; 17(10):e0273620. PubMed ID: 36269711
[TBL] [Abstract][Full Text] [Related]
40. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
